#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Multiple system atrophy Pulmonary fibrosis Pustular psoriasis Retinoblastoma Loss of consciousness Paget's disease of the vulva Factor IX deficiency Vascular calcification Pleural mesothelioma Henoch-Schonlein purpura nephritis Marfan's syndrome Metachromatic leukodystrophy Solitary fibrous tumour Adenomatous polyposis coli Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Hypereosinophilic syndrome – Diagnostics Hepatic angiosarcoma – Diagnostics Friedreich’s ataxia – Basic Information MELAS syndrome – Treatment Phenylketonuria – Basic Information Leukoencephalopathy – Life with Disease Paraneoplastic neurological syndrome – Life with Disease Chronic granulomatous disease – Diagnostics Systemic sclerosis pulmonary – Treatment Carcinoid syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Trospium Chloride Fluasterone Levetiracetam Tralokinumab Dextran 70 Datopotamab Deruxtecan Clodronate Disodium Nadroparin Calcium Lorundrostat Odronextamab Forimtamig Mometasone Furoate M1P Dipotassium Salt Fexofenadine Hydrochloride Triamcinolone Acetonide Sqy51 Fianlimab Metoprolol Succinate Maridebart Cafraglutide Dexketoprofen Trometamol More therapies…

    Learn about Your Condition

    Non-small cell lung cancer Huntington's disease Haemorrhoids Coeliac disease Primary amyloidosis Piriformis syndrome Seizure Depression Intestinal ischaemia Lymphangiosarcoma Alcohol use disorder Decreased appetite Muscle strain Peripheral artery stenosis Myocardial infarction More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Hopitaux Universitaires Pitie Salpetriere

Hopitaux Universitaires Pitie Salpetriere

47 Boulevard De L Hopital, Paris, 75651, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing Integrase Inhibitor (Bictegravir) and Boosted Protease Inhibitor (Darunavir) Treatments for Patients with Advanced HIV Infection

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • HIV infection
    Investigated Drugs:
    • Bictegravir
    • Cobicistat
    • Darunavir
    Belgium France Germany Ireland Italy Spain

  • Study on the Effects of Upadacitinib in Adults with Moderate to Severe Systemic Lupus Erythematosus (SLE)

    Not recruiting

    3 1
    Investigated Drugs:
    • Upadacitinib
    Belgium Bulgaria Croatia Estonia France Germany +10

  • Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Tafasitamab
    • Lenalidomide
    • Rituximab
    Austria Belgium Czechia Denmark Finland France +10

  • Study on Adding Ipilimumab to Atezolizumab and Bevacizumab for Patients with Liver Cancer Receiving First-Line Treatment

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • Atezolizumab
    • Bevacizumab
    • Ipilimumab
    France

  • Study of Tolinapant with Decitabine and Cedazuridine for Patients with Relapsed or Refractory Peripheral T-cell Lymphoma

    Not recruiting

    1 1 1
    Investigated Drugs:
    • Cedazuridine
    • Decitabine
    • Tolinapant Lactate
    France Hungary Italy Poland Spain

  • Study of Ezurpimtrostat with Atezolizumab and Bevacizumab for Patients with Unresectable Liver Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Gns561
    • Atezolizumab
    • Bevacizumab
    France

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Richter’s syndrome
    Investigated Drugs:
    • Alpelisib
    • Anhydrous Cyclophosphamide
    • Betamethasone Sodium Phosphate Ph. Eur
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hairy cell leukaemia
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Betamethasone Sodium Phosphate Ph. Eur
    • Brexucabtagene Autoleucel
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Burkitt’s lymphoma
    Investigated Drugs:
    • Alpelisib
    • Anhydrous Cyclophosphamide
    • Betamethasone Sodium Phosphate Ph. Eur
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Waldenstrom’s macroglobulinaemia
    • Waldenstrom’s macroglobulinaemia refractory
    Investigated Drugs:
    • Anhydrous Cyclophosphamide
    • Betamethasone Sodium Phosphate Ph. Eur
    • Brexucabtagene Autoleucel
    Austria France Germany Italy The Netherlands Spain +1
Previous Page
1 … 15 16 17 18 19 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!